Database for the Assessment of Efficacy and Safety of BPH Treatment

Recruiting Observational Study
Lower Urinary Tract Symptoms Benign Prostatic Hyperplasia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Dominik Abt · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG * Patient age ≥ 18 years * Informed consent provided Exclusion Criteria: -Cognitive impairment not allowing Informed Consent or adequate data assessment.
Contacts

Dominik Abt, MD

+41 71 494 14 16

dominik.abt@kssg.ch

CONTACT

Gautier Müllhaupt, MD

+41 71 494 14 16

Gautier.muellhaupt@kssg.ch

CONTACT